Jul 3 |
Natera (NTRA) Soared After a 43% Increase In Revenue
|
Jul 3 |
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
|
Jul 3 |
Natera's (NASDAQ:NTRA) investors will be pleased with their massive 314% return over the last five years
|
Jul 3 |
Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
|
Jun 27 |
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
|
Jun 20 |
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
|
Jun 19 |
Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
Jun 17 |
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
|
Jun 3 |
Natera: Overdue For A Breather
|
Jun 3 |
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
|